Whakakotahi 2019 final
Contents Context
.......................................................................................................................... 4
Introduction ................................................................................................................................ 6 Background ................................................................................................................................ 7 Project scope ...........................................................................................................................11 Who can apply? .......................................................................................................................12 Eligibility criteria .......................................................................................................................13 Application process ..................................................................................................................13 Due date for applications .........................................................................................................14 Further information...................................................................................................................14 Evaluation guidelines ...............................................................................................................15 Equity .......................................................................................................................................15 Medicine access equity ............................................................................................................15 Consumer engagement ...........................................................................................................15 Integration ................................................................................................................................16 Evaluation criteria ....................................................................................................................17 Application form for all projects ...............................................................................................23
Page 2 of 26
“
Our organisation participated in the first Whakakotahi programme.
Our goals included improving health outcomes for patients with diabetes, actively engaging with whānau to improve service delivery and learning some new quality improvement tools. We formed a patient advisory group, Te Kete Hauora to help oversee our diabetes project. I joined other Māori & Pacific patients on our project team and helped spread our learnings in the community. We had a lot of fun together, sharing whakapapa and personal experiences. Our nurses, doctors and specialists got to understand us better too. Best of all, this lead us to co-designing a 12-week exercise programme (Toiora) together in our community.
Ehara taku toa i te toa takitahi, ēngari he toa takitini.
”
Success is not the work of one, it is the work of many. Muriel Tunoho Kaukawa ki uta. Raukawa ki tai Whakakotahi 2017 improvement team member Read about a day in the life of the Toiora exercise class on the Health Quality & Safety Commission’s website: www.hqsc.govt.nz/our-programmes/primary-care/news-andevents/news/3198/.
Page 3 of 26
Context Welcome to the application pack for Whakakotahi 2019 – the primary care quality improvement challenge. Whakakotahi is a primary care initiative from the Health Quality & Safety Commission (the Commission). ‘We are responsible for assisting providers across the whole health and disability sector – private and public – to improve service safety and quality and therefore outcomes for all who use these services in New Zealand.’ Professor Alan Merry, Chair, Health Quality & Safety Commission
Our mission To work with everyone to ensure New Zealand has the highest quality health care. To achieve this mission, we work towards achieving the New Zealand triple aim for quality improvement of: • • •
improved quality, safety and experience of care improved health and equity for all populations best value for public health system resources.
Ko te whāinga rangatira hei tūāpapa mō Te Kupu Taurangi Hauora o Aotearoa; Ko te whakatutuki i te mana taurite hauora mō ngā tāngata puta noa i te motu. Ko ngā mātāpuna o Te Tiriti o Waitangi hei whāriki e whai ake i tēnei moemoeā. The aim of the Health Quality & Safety Commission is to achieve health quality improvement and equity for all. The principles of the Treaty of Waitangi are a basis upon which we strive to achieve this aspiration.
Responsibilities under the Treaty of Waitangi We recognise our responsibilities to uphold our obligations under the Treaty of Waitangi. We use the widely accepted interpretation of the Treaty principles of partnership, participation and protection of Māori. Through the principles, Māori advancement is a vital component of quality health care. Wherever possible, we will work to improve the quality and outcomes of care for Māori, and address any systemic inequity. The relationships and partnerships we build with Māori stakeholders, particularly Te Roopū Māori, our Māori advisory group, are fundamental to this work. Māori cultural concepts, such as whānau ora, will help us appropriately incorporate a Māori focus into our work. We are focused on improving health equity by adopting Māori-centred improvement methods, and work towards kaupapa Māori health quality improvement programmes. We will promote a culture that addresses quality health outcomes for Māori through open
Page 4 of 26
discussion, Māori-centred programme design, professional development and mentoring programmes. A crucial vehicle for this work is Te Whai Oranga, our Māori advancement framework, which is helping to define our priorities and approach.
Our values Our work is underpinned by six values: Ngākau tuwhera / Open; Te tāpiri uara / Adding value; Whakahohe / Energising; Mō te iwi / It's about people; Kotahitanga / Together. Read more about our values on our website: www.hqsc.govt.nz/about-us/our-vision-andvalues/.
Our strategic priorities The Commission’s Statement of Intent (2017–21) outlines four strategic priorities: • • • •
improving consumer/whānau experience health equity reducing harm and mortality reducing unwarranted variation in patterns of care.
Health equity is the key priority for Whakakotahi 2019 This priority acknowledges that different population groups receive unequal benefits from our health and disability system. We only have to look at life expectancy statistics to know this, for example, while New Zealanders overall are living longer, there is a difference of more than five years life expectancy between Māori and New Zealand European populations. Children are another population group that, being dependent on others for care, may not access the health services they need 1. New Zealanders report economic barriers in accessing health care, which are increasing and becoming more common among Māori and people with low socioeconomic status 2. We will contribute to a stronger understanding of health equity through our measurement and evaluation reporting and tools, and will make addressing inequities part of our improvement initiatives, where possible. The Commission acknowledges the important role the primary care sector can play in addressing health inequities.
1
2
https://www.hqsc.govt.nz/assets/CYMRC/Publications/CYMRC-13th-data-report-FINAL-Apr-2018.pdf https://www.hqsc.govt.nz/our-programmes/health-quality-evaluation/publications-and-resources/publication/3364/
Page 5 of 26
Introduction This document describes Whakakotahi 2019 – the primary care quality improvement challenge. Whakakotahi is a primary care initiative the Commission will work on with primary care and community providers. This document establishes a common understanding to inform applications to deliver primary care quality improvement projects as part of the ‘challenge’. The project scope (see page 11) describes Whakakotahi and the types of initiatives being sought from primary care organisations. This document includes: • • • •
details about how to apply (see page 13) eligibility criteria (see page 13) evaluation guidelines (see page 15) an application form (see page 23).
To apply, providers should submit an application no later than 12 noon on 31 August 2018. A selection panel will select a shortlist from the applications received by this date. The Commission will work with the shortlisted applicants to complete a more detailed proposal; the final selection will be made from these updated proposals. For further information, please visit the Commission’s website: www.hqsc.govt.nz.
Page 6 of 26
Background The Health Quality & Safety Commission The Commission was established in November 2010 to: • •
measure and monitor the quality and safety of health and disability services work with clinicians, providers and consumers to improve the quality and safety of health and disability services.
We develop systems and processes to ensure the safest and highest quality care, using proven innovation, and learning from mistakes so they do not happen to others.
An increased focus on primary care To support the New Zealand triple aim for quality improvement, the Commission has increased its focus on primary care and community services, aged residential care, and disability services. In 2014, the Commission hosted a workshop with primary care opinion leaders to identify important quality and safety issues, and understand how the Commission may best contribute. This led to the establishment of the primary care expert advisory group (EAG) in 2015. Find out more about the group on the Commission’s website: www.hqsc.govt.nz/our-programmes/primary-care/expert-advisory-group/. The EAG, chaired by Dr John Wellingham, supports the Commission’s engagement with primary care providers, provides a primary care perspective on the Commission’s work, and advises on all of the Commission’s primary care work and on future initiatives. In response to the EAG’s advice, the Commission agreed to a stronger focus on primary care. In the first instance, this involves the Commission partnering with primary care teams to work on small-scale quality improvement projects – this is Whakakotahi (te reo Māori for ‘to be as one’). This word was identified by EAG members as best describing the emerging partnership and collaboration between the primary care sector and the Commission. Whakakotahi is strongly aligned with the Commission’s value of kotahitanga: Kotahitanga: Ka hono mātau me ētahi atu, me te ako ngātahi, tuari hoki. Together: We partner with others, and learn and share together. Whakakotahi aligns with current government priorities focused on equity and primary care. It also focuses on two key deliverables outlined in the Minister of Health’s letter of expectation to the Commission for 2018–19: • •
supporting implementation of the system level measures in the health system, by raising improvement science capability in primary care implementing a quality improvement programme to reduce health inequities.
Page 7 of 26
Primary care quality improvement capability building The primary care sector has a strong motivation to undertake quality improvement activities. However, we recognise that there is limited capacity (funding and time) and capability (knowledge and skills) for such activities. More specifically, the aim of Whakakotahi is to increase quality improvement capability in primary care, with the following goals: • • • •
•
build collaborative partnerships between the Commission and primary care to improve primary care quality and the Commission’s understanding of it improve one or more health outcomes with associated improvements in equity, integration and consumer engagement support sector-led improvement projects to build and spread improvement science expertise and skills in the primary care sector identify improvement projects/initiatives that are suitable for implementing at a local, regional or national level (as appropriate) support the implementation of the system level measures framework, by linking improvement projects to the framework and raising improvement science capability in the primary care setting.
Whakakotahi primary care improvement challenge In 2016, the Commission’s primary care programme launched Whakakotahi. The first year, Whakakotahi 2017, drew 16 applications with 3 teams successfully going through to the improvement phase. The second year, Whakakotahi 2018, drew 22 applications with 6 teams selected. These teams accepted the ‘challenge’ of applying for a place in Whakakotahi, and stepping up to learn about and apply improvement science to improve the quality of their patients’ care. For the third year (Whakakotahi 2019), we are looking for up to 12 new teams.
Health equity is the key priority for Whakakotahi 2019 A Māori cultural advisor will join the primary care programme team to support the delivery of Whakakotahi 2019. We will bring all of the improvement teams together for three group learning events for quality improvement teaching and workshops, idea sharing, and networking. Between these group learning events, the Commission’s quality improvement advisor and project manager will provide virtual and on-site support and mentoring to the improvement teams, as needed.
Page 8 of 26
PHARMAC partnership We are excited to announce that we will be partnering with PHARMAC for Whakakotahi 2019. This will see a ‘medicine access equity’ focus introduced into this year’s application process. This is in line with the Commission’s focus on primary care quality improvement and equity, and PHARMAC’s commitment to ensuring all New Zealanders have equitable access to medicines. PHARMAC’s commitment to medicine access equity is manifested in a number of ways, including ‘bold goal one: eliminating inequities in access to medicines’, a goal that PHARMAC aims to achieve by 2025. Their work in medicine access equity is about making sure different population groups, particularly those already experiencing health inequities, can access and utilise funded medicines equitability. Three (3) of up to 12 improvement projects selected for Whakakotahi 2019 will have a medicine access equity focus. Teams who focus their improvement efforts on addressing medicine access inequities will receive additional support from PHARMAC’s principal adviser, access equity, as needed. More information about PHARMAC’s bold goal is available on their website: www.pharmac.govt.nz/about/2017/bold-goal-1/.
Looking ahead Whakakotahi is the start of the journey. While we collectively and incrementally build improvement science capability and progress the selected Whakakotahi improvement projects, the Commission will continue to work with a broad range of primary care stakeholders and partners. This will lay the groundwork for future improvement work in the sector, including opportunities for scale and spread.
Financial contribution The Commission will contribute towards the costs associated with back-filling positions. This funding is designed to enable organisations to release team members involved in Whakakotahi, so they can undertake their improvement project work and attend learning events (ie, onsite visits and group learning events). In effect, the Commission will reimburse staff time up to $6000 (excluding GST) for each selected improvement project. The Commission will also fund reasonable travel costs to support team member attendance at the group learning events (three (3) members, per team, at each event). These events will be held three times during the improvement project and will usually take place in Auckland, Wellington, or other main centre. In addition, a scholarship will also be offered to enable one (1) team member from each of the successful Whakakotahi 2019 teams to participate in the 10-month-long primary care
Page 9 of 26
improvement facilitator course delivered by Ko Awatea. The goal of this customised quality improvement facilitator programme is for participants to become highly effective leaders in helping their organisations accomplish improvement plans (eg, system level measures plans) through immediate application of the skills they learn. In summary, the Commission will provide: • • •
$6000 per project team (excluding GST) to support back-filling of roles while team members undertake their improvement work/attend learning events funding of travel costs to support team member attendance at group learning events (three [3] members, per project team, at each event) a scholarship to enable one (1) team member from each project team to participate in the 10-month-long ‘primary care improvement facilitator’ course delivered by Ko Awatea.
Page 10 of 26
Project scope The Commission is seeking applications for primary care quality improvement projects. Applicants are welcome to submit proposals about any facet, element or area of patient care that they would like to improve, and one that is important to their patients/community, and to them as providers of care.
You get to choose the initiative! Priority areas Initiatives for Whakakotahi must support one or more of the Commission’s three primary care strategic priority areas. •
Equity: all projects must be strongly focused on equity in the design, implementation and evaluation phases. The Commission’s partnership with PHARMAC means that in 2019 there is also an opportunity to submit projects and initiatives that specifically focus on medicine access equity (see page 20).
•
Consumer engagement: consumer co-design will enable projects to move from ‘consumer experience’ to ideally reflect consumer journeys through health, including their impact on quality of life.
•
Integration: integrated patient-centred care will be a key priority to provide seamless transitions of care. The project should target, from the consumer perspective, either the vertical gap between primary care and secondary care, or the horizontal gaps across primary care and with other social sector services.
Whakakotahi work programme The Commission will work with the successful applicants on their quality improvement projects following a structure similar to the Institute for Healthcare Improvement’s breakthrough series (collaborative) methodology, underpinned by the model for improvement. We will be guided by successful applicants about the 'how' part of the improvement phase. We will adapt the style of support, methodology and quality improvement approach depending on what works best for you, your team, patients, and organisation; this includes acknowledgement of tikanga and kawa.
Page 11 of 26
Whakakotahi activity Planned activities Whakakotahi 2017 • Three projects were selected; the teams are currently completing their improvement work. • For more information, please visit our website: www.hqsc.govt.nz/ourprogrammes/primary-care/whakakotahi/whakakotahi-2017/. Whakakotahi 2018 • Six projects were selected; the teams began the improvement phase in January 2018. • For more information, please visit our website: www.hqsc.govt.nz/ourprogrammes/primary-care/whakakotahi/whakakotahi-2018/. Whakakotahi 2019 • We anticipate up to 12 new projects for this cohort, with three (3) of these having a medicine access equity focus. • Support capability building in the new and ongoing improvement projects. • Identify additional initiatives that are amendable to spread/scale. • Scope possible national approach to spread/scale of initiatives/quality improvement capability. Whakakotahi 2019–20 • Sustain the improvement network created by Whakakotahi (Commission acting as a ‘hub’). • Support incremental/regional spread/scale of successful projects. • Coordinate a national approach to spread/scale of initiatives/quality improvement capability.
Who can apply? All primary care providers are invited to apply for Whakakotahi 2019 including general practice, community pharmacy, Māori health, Pacific health or other primary care providers. We encourage applications from Whānau Ora provider collectives. We invite applications from other primary care providers without a general practice focus. Applications that will involve larger groups of primary care providers (three or more) working on a specific project are encouraged. The primary health organisation (PHO) and/or district health board alliance network would be expected to provide quality improvement and financial support for the project to complement the Commission’s input. All applications should be submitted with the endorsement and support of a PHO.
Page 12 of 26
Eligibility criteria The Commission invites applications from primary care providers who meet these criteria: • •
The proposed improvement project is focused on quality improvement in the New Zealand primary care sector. Proposals must be for activities commencing in 2019, through to 2020.
The Commission will not consider applications for: • • • • • •
capital expenditure IT software or hardware projects projects with commercial application pharmaceuticals research and development or research undertaken as part of an undergraduate or postgraduate programme attendance at conferences or seminars international travel.
Application process Applications must be sent by email to the address below and must arrive before the due date. Applications must be on the attached form (see page 23) and contain the information set out in the evaluation sections (see page 15). Applications will be acknowledged by email. The Commission has a five-stage process for receiving and processing applications. Stage 1 12 July– 31 August 2018
Short application
Stage 2 3 September– 3 October 2018
Shortlisting
Stage 3 4 October–21 November 2018
Full proposal templates completed
Applications will be accepted during this period.
The selection panel will review all applications and prepare a shortlist if required.
Shortlisted applicants notified who will then complete a full proposal with assistance from the Commission. We will contact applicants at the earliest opportunity to allow this information to be collated. Applicants should be aware of the additional information required when resubmitting their improvement project proposal.
Page 13 of 26
Stage 4 22 November– 17 December 2018
Interviews and selection process
Stage 5 18 December 2018– 25 January 2019
Memorandum of understanding negotiations and startup
Applicants will be invited to connect with the selection panel via teleconference for a brief Q&A session about their proposal. The selection panel will then make recommendations to the Commission on the preferred proposals. Applicants will be advised about the outcome of the final selection process by 17 December 2018.
The Commission and successful applicants will finalise a memorandum of understanding (MOU). Improvement project start-up will commence in January 2019 and finish by June 2020.
Due date for applications Applications are invited from 12 July 2018 and close at midday on 31 August 2018. Memorandums of understanding will be completed by 25 January 2019. Applications should be emailed to primarycare@hqsc.govt.nz.
Further information If you have any questions, please contact Jane Cullen (quality improvement advisor): Phone: 021 973 470 Email: jane.cullen@hqsc.govt.nz
Page 14 of 26
Evaluation guidelines The key criteria required for applications to fulfil each of the Commission’s strategic priority areas are explained below. We have obtained expert advice from the primary care sector to identify these criteria. Each application will be assessed against these criteria by a selection panel.
Equity • •
• •
Use an existing evidence base of qualitative and quantitative data to explain the problem in a local context, including inequities between population groups. Include a clear description of the equity outcomes that the improvement project will achieve (in practice, this will mean that data is able to be monitored and grouped according to the identified population inequities). Demonstrate understanding of how these inequities have arisen, and how the proposed approach differs from the current state (why this needs to happen). Demonstrate an understanding of and commitment to equity-enhancing actions. This should include equitable representation from the local population, focusing on collaborative community participation, as well as partnering with other experts to address inequities.
Medicine access equity •
Projects with a focus on medicine access equity will be evaluated against equity, consumer engagement, integration, and additional related evaluation criteria (see page 17).
Consumer engagement • •
• •
•
•
Describe the improvement the provider wants to achieve, and how this is a quality improvement activity centred on consumer engagement. Show commitment to consumer co-design and involving the consumer in every stage of the improvement project. Consumer engagement should feature throughout the improvement project, from scoping, through project governance to evaluating outcomes. (Ideally) Be consumer initiated – brought to the provider’s attention by the community, with accountability back to the community through the evaluation process. Demonstrate how consumers are valued, supported and trained appropriately so they can participate fully in the improvement project from the outset. There will be evidence of value of a collaborative and consensus-building approach. Focus on patient experience and the patient journey, concentrating on issue(s) that are important to the consumer. Any barriers will be stated and understood from a local consumer perspective. Demonstrate the team’s willingness to change as a result of the improvement project and respond to feedback from consumers during the evaluation process, even if that means further unforeseen change is required.
Page 15 of 26
Integration •
•
•
Articulate a shared understanding of the integration problem (current state) and that all parties have a shared vision and understanding of the changes required to reduce waste and fragmentation. Embody the concept of ‘teams without walls’. It will identify the relevant parties and their accountabilities across roles, responsibilities and funding. Joint governance, decisionmaking and co-design processes will support the initiative. Focus on consumer needs and their journey to create integrated pathways that deliver improved care, as well as understanding the wider relationships that are important to the consumer, so that their supporting infrastructure is woven throughout the programme. The project will consider health literacy needs, and what actions may be required to address them.
Page 16 of 26
Evaluation criteria Applications will also be assessed against either of the following criteria.
Summary of general evaluation criteria The general evaluation criteria include: • • • • • •
equity consumer engagement integration multi-disciplinary teams multi-site projects spread/scalability/sustainability.
Summary of general evaluation and medicine access equity criteria •
All of the above, with a focus on eliminating medicine access equity in primary care, for medicines already funded by PHARMAC in primary care, and in populations already experiencing health inequities.
The Commission will provide brief feedback to applicants whose proposals are not successful. The selection panel’s decisions will be final and not subject to review.
Weightings The key principles of equity, integration and consumer engagement will be weighted during the scoring process used by the selection panel as follows: • • • •
equity: 50 percent consumer engagement: 30 percent integration: 10 percent other: 10 percent.
What is your focus? When applying for Whakakotahi, please decide about whether you want your project to be considered against: • •
the general evaluation criteria (see page 18) or the general evaluation criteria with a focus on medicine access equity (see page 20).
Please contact us if you have any questions.
Page 17 of 26
General evaluation criteria Criteria
Description
Strategic fit with Commission priorities
Does the proposal align with the Commission’s strategic priority areas? • • • •
Priority 1: Improving consumer/whānau experience Priority 2: Improving health equity (see below) Priority 3: Reducing harm and mortality Priority 4: Reducing unwarranted variation in patterns of care.
Does the proposal align with other agencies’ and the health sector’s priorities? •
• •
Does the problem affect some population groups more than others? Who are these groups? What are the origins of existing inequities? Does the proposed project contribute to equitable health outcomes? How will the proposal promote health equity? How will this initiative decrease existing inequity? How will inequity be measured? What are the potential impacts on Māori health?
•
How will your project involve consumers?
Integration
•
How will the project contribute to integration of service delivery and patient-centred care?
Evidence
•
Does the proposal relate to a known and clearly defined problem? How well stated is the problem definition? What is the size and impact of the problem identified? What are the possible/probable causes for this problem? Is the problem to be addressed amenable to change taking into account, for example time/resource constraints? How strong is the evidence for the proposed changes in practice or interventions proposed? How are the proposed changes linked to the identified causes of the problem? Is there support for this improvement area/topic in the sector? Are there any potential unintended consequences that may need to be addressed?
Equity
• • •
Consumer engagement
• • • •
• • • •
Page 18 of 26
Achieving proposed goals
• • • • • • • • •
What are the benefits of the proposed solution? How easy will it be to measure benefit from the project? Is there potential for significant health gain and/or reduced risk/harm/inequity? What is the timeframe for achieving improvement? Can the proposed ideas for change/improvement be easily and sustainably incorporated into practices? How will the changes be sustained over time? What short- and long-term costs will be incurred? What support for this proposal will be provided by others in the sector? What are the perceived risks in this proposal for the organisation, the consumer and the Commission?
Page 19 of 26
General evaluation criteria with a focus on medicine access equity If you are applying with an improvement project that focuses on medicine access equity, please address the following criteria, along with the general evaluation criteria. While addressing these specific equity criteria, please remember to fulfil all of the Commission’s overarching strategic priority areas (see page 11). Criteria
Description
Medicine access
Describe the medicine access equity problem you are looking to address through your initiative.
Note: PHARMAC’s medicine access equity driver diagram (www.pharmac.govt. nz/medicines/equity/ ) identifies four primary drivers and related secondary drivers that facilitate access to funded medicines. Most of these drivers sit outside the direct control of PHARMAC and can be significantly influenced by primary care providers. Projects should clearly identify which primary and secondary drivers their initiative is contributing towards.
•
•
How will your project make measurable improvements in the equity of medicine access through one or more of drivers as identified in PHARMAC’s medicine access equity driver diagram: (www.pharmac.govt.nz/medicines/equity/)? How will your project improve access for a particular medicine, a group of medicines, or for specific conditions (acute or long term)?
Priority will be given to projects that specifically focus on improving medicine access equity for medicines (or conditions for which medicines) are already funded by PHARMAC in primary care.
Page 20 of 26
The concept of ‘medicine access’ includes both the initial access which is the first time a prescription for a funded medicine is written and filled, and ongoing access to prescriptions and medicines (referred to as ‘persistence’). Practice setting Priority will be given to projects that are submitted by providers delivering services in the primary care/community setting.
Describe the practice setting(s) within which your initiative will be conducted. It will be useful to include details of your team’s makeup as well as a description of any other providers/agencies you will be collaborating with for this initiative, if applicable.
Note: projects will also be considered if the medicine access equity issue described is related to a hospital/secondary care initiating and primary care continuing treatment. Priority populations Medicine access equity projects that are looking to improve access to medicines in populations that share one or more of the following characteristics will be given priority: • • •
•
Describe which groups/communities of people you will focus on, to improve their access to funded medicine in a manner that is equitable, and why you chose them.
Māori and/or Pacific peoples socioeconomic deprivation refugees (including people from former refugee background) sub-regionally deprived populations (refers to geographical areas of NZ where residents face
Page 21 of 26
significantly greater health disparities than other geographical areas). Note: this is not a mutually exclusive list; in fact, it is likely the most deprived individuals (and communities) will share more than one of these characteristics.
Page 22 of 26
Whakakotahi 2019 Primary care quality improvement challenge Application form for all projects Please complete all sections of this form using it as a template for your application. Refer to the evaluation guidelines when completing this form. Please use the text boxes for each section; you can expand the text boxes as required. If you have any questions about the amount or type of detail to include in your application, or need help to complete this application form, please feel free to contact Jane Cullen (quality improvement advisor): Phone: 021 973 470 Email: jane.cullen@hqsc.govt.nz Section 1: Project details Short title of project Project location (the region, town or city where the project will be based). If this application is related to any other proposals, note them here. Please specify if you are applying under the: a) general evaluation criteria or b) general evaluation criteria with a focus on medicine access equity.
Section 2: Applicant’s details Legal entity or entities applying. For joint ventures between two or more entities note the lead entity and attach an endorsement for their lead role from the other related organisations.
Page 23 of 26
Primary contact person’s name Primary contact’s details •
Phone
•
Mobile
•
•
Postal address
Person who will be delivering the project (if known and not primary contact) Provide a brief description of your organisation(s)/practice(s)/pharmacy(ies) etc. This can include: • size • enrolled population • population characteristics eg, ethnicity or proportion of high need. • very low cost access practice (VLCA) • integrated family health centre (IFHC) • other special characteristics.
This description helps the Commission to assess equity.
Are there any potential or perceived conflicts of interest you are aware of in this proposal? If so, please declare these.
For example: Is anyone involved in this project working for the Commission in any capacity, or possess a commercial interest in the outcome of the project?
Section 3: Project information Evidence What is the problem you are trying to address?
Describe the problem and how you know that this is a problem.
Why is this a problem? What is the scale and scope of the problem?
Provide quantitative and/or qualitative data about the problem, including data about existing inequities.
Page 24 of 26
What are you proposing to do?
Describe your ideas for change. For projects with a medicine access equity focus, identify the primary and related secondary drivers the project is likely to impact.
Section 4: Project objectives Please use extra space if required to describe your project. Strategic fit How will this project contribute to the three strategic priority areas for primary care including: • • •
equity and, if applicable, medicine access equity? consumer engagement? Integration?
Achieving your goals •
How will you know if you have made a difference?
•
How will you monitor your project delivery and success?
•
What is the timeframe for achieving improvement?
•
How well would your project transfer to other health providers?
Does the problem affect some population groups more than others? How will the proposal seek to address health equity or medicine access equity? Review the evaluation guidelines on page 15 and provide a description of how your proposal will meet these criteria and if applicable medicine access equity criteria. What data/measures will you collect and how will you collect them? How much data do you already have? Please explain how the focus areas would be measured: • equity and, if applicable, medicine access equity • integration • consumer engagement. Describe the possible barriers and obstacles that might hinder your improvement efforts. How long will you need to show sustainable change? What are the opportunities for your initiative to be spread across the sector and how can sustainability be assured?
Page 25 of 26
Resourcing Briefly describe how your organisation will resource and support your improvement project. PHO support Briefly describe how your PHO has endorsed your proposal.
Section 5: Certification I, ________________certify that this application to Whakakotahi 2019 – primary care quality improvement challenge is authorised by the legal entity specified above. Application requirements
Please tick when complete ✓
All applications must be received by the Commission by midday on 31 August 2018. All applications must be completed correctly and contain the information requested. Please specify if you are applying under the general evaluation criteria or the general evaluation criteria with a focus on medicine access equity. Nominate a primary contact for administrative purposes, including name, contact number, email and address. Joint ventures between organisations should identify a lead organisation, and include an indication of endorsement for their involvement in this project from the other organisations. Indication of endorsement from PHO (eg, email or scanned letter of support). Application should be emailed to primarycare@hqsc.govt.nz by midday on 31 August 2018.
Page 26 of 26